Cholesterol + Antioxidants for Smith-Lemli-Opitz Syndrome
This trial involves giving SLOS patients extra cholesterol and antioxidants to manage their condition. The treatment helps by providing necessary cholesterol and protecting against harmful substances. The goal is to improve health outcomes for these patients. Smith-Lemli-Opitz syndrome (SLOS) has been previously treated with cholesterol supplementation and statins to manage cholesterol synthesis defects.
Behavioural Intervention
Enhanced Hearing Screening + Telemedicine Referral for Childhood Hearing Loss
This trial will evaluate a new way of screening for and referring children with hearing problems in rural schools, using mobile health tools and telemedicine.
Behavioural Intervention
Smart Hearing Aids for Fall Risk and Speech Clarity
This trial aims to create and test hearing aids with sensors and AI to help assess and reduce the risk of falls, improve speech clarity, track activity levels, and social interactions. The goal is to use
Behavioural Intervention
Hearing Aid Enhancements for Hearing Loss
This trial is investigating whether three different approaches can improve hearing for people who use hearing aids. The approaches being tested are increased high-frequency audibility, speech envelope enhancement, and appropriate sound image externalization.
Popular Filters
Trials for Sensorineural Hearing Loss Patients
Behavioural Intervention
Speech-Language Teletherapy for Hearing Loss
This trial will study whether speech and language teletherapy can help improve outcomes for deaf or hard-of-hearing children. 140 children who are publicly insured will be randomly assigned to either receive the therapy or usual clinical care, while 70 privately insured children will only receive usual care. Assessments will be done at the start of the study and then every 9 months to see if there are any improvements.
Behavioral Intervention
Accessible Hearing Care Interventions for Hearing Loss
This trial will study how well three different interventions work to improve quality of care for adults with mild-to-moderate hearing loss who don't have access to hearing healthcare.
Trials for SPHL Patients
Behavioural Intervention
Speech-Language Teletherapy for Hearing Loss
This trial will study whether speech and language teletherapy can help improve outcomes for deaf or hard-of-hearing children. 140 children who are publicly insured will be randomly assigned to either receive the therapy or usual clinical care, while 70 privately insured children will only receive usual care. Assessments will be done at the start of the study and then every 9 months to see if there are any improvements.
Behavioral Intervention
Accessible Hearing Care Interventions for Hearing Loss
This trial will study how well three different interventions work to improve quality of care for adults with mild-to-moderate hearing loss who don't have access to hearing healthcare.
Trials With No Placebo
Behavioural Intervention
Speech-Language Teletherapy for Hearing Loss
This trial will study whether speech and language teletherapy can help improve outcomes for deaf or hard-of-hearing children. 140 children who are publicly insured will be randomly assigned to either receive the therapy or usual clinical care, while 70 privately insured children will only receive usual care. Assessments will be done at the start of the study and then every 9 months to see if there are any improvements.
Behavioral Intervention
Accessible Hearing Care Interventions for Hearing Loss
This trial will study how well three different interventions work to improve quality of care for adults with mild-to-moderate hearing loss who don't have access to hearing healthcare.
Behavioral Intervention
Parent Training for Childhood Hearing Loss
This trial will test an adapted version of an evidence-based parent training intervention to help parents of young deaf and hard of hearing children, in order to prevent costly long-term behavioral problems.
View More Related Trials
Frequently Asked Questions
Introduction to hearing loss
What are the top hospitals conducting hearing loss research?
When it comes to advancing the field of hearing loss research, several top hospitals are leading the way. The Vanderbilt University Medical Center in Nashville is at the forefront with five active clinical trials dedicated to understanding and treating hearing loss. With a total of 15 trials conducted since their first recorded trial in 2011, this institution's commitment to finding innovative solutions is evident. In Jackson, Mississippi, the University of Mississippi Medical Center has made significant contributions as well. Currently conducting four active hearing loss trials and having completed three previous studies since recording their first trial in 2019, they are actively working towards improving outcomes for individuals affected by hearing impairment.
Nationwide Children's Hospital in Columbus also plays a crucial role with its ongoing dedication to hearing loss research. They currently have four active clinical trials focused on better understanding this condition and find ways to offer effective interventions. Having started their initial trial only three years ago in 2018, they have quickly established themselves as key players in this field.
The University of Iowa in Iowa City joins these institutions' efforts by devoting resources to studying and addressing hearing loss through four ongoing clinical trials. Their involvement spans over sixteen years since initiating their first recorded trial on this subject back in 2004 resultingin fourteen various experiments held till date.Their work contributes significantly towards expanding our knowledge about this prevalent condition.
Lastly, we turn our attention to Los Angeles where the renowned University of Southern California is making notable strides against hearing loss with its current portfolio of four active clinical trials. Despite joining the pursuit most recently with its inaugural trial starting just last year (2020), they already make a meaningful impact alongside other established institutions across different regions.
Together, these hospitals represent beacons of hope for those experiencing auditory challenges while highlighting that advancements can occur from diverse locations across America By continuously pushing boundaries through groundbreaking research endeavors; we move closer towards improving prevention strategies,treatments,and ultimately enhancing quality life experiencesfor countless individuals struggling with hearing loss.
Which are the best cities for hearing loss clinical trials?
When it comes to hearing loss clinical trials, several cities emerge as top contenders for groundbreaking research. New york leads the pack with 16 active trials investigating treatments such as Valganciclovir, Ebselen, and Vagal Nerve Stimulation during Cochlear Implantation Surgery. Los Angeles follows closely behind with 11 ongoing studies focusing on interventions like Ebselen, Montelukast, and Voice lessons. Saint Louis showcases promising research with 10 active trials exploring treatment options ranging from chemoradiotherapy to Electrocochleography. Chicago also plays a significant role in hearing loss research with 9 active trials studying Hearing Aids, DTC Hearing Aid, and Valganciclovir among others. Lastly, Seattle contributes to the field with 8 active trials that investigate various interventions including Usual Care + Teletherapy (Low-Income) and DB-OTO - Dose Escalation. These cities provide individuals experiencing hearing loss access to cutting-edge clinical trials that pave the way for improved care and potential breakthroughs in this domain of healthcare.
Which are the top treatments for hearing loss being explored in clinical trials?
The quest to find effective treatments for hearing loss is ongoing, fueled by innovative research and clinical trials. Among the top contenders is an experimental treatment currently being explored in two active trials specifically focused on hearing loss. This pioneering therapy made its debut in 2012 and has since accumulated one all-time trial dedicated to addressing this challenging condition. As scientists continue their efforts, these clinical trials offer hope for advancements that could transform the lives of individuals affected by hearing loss worldwide.
What are the most recent clinical trials for hearing loss?
Recent clinical trials offer hope for individuals with hearing loss, as researchers explore innovative approaches to address this prevalent condition. One such trial focuses on the effectiveness of high-dose ORC-13661 in treating hearing loss, with promising results emerging from Phase 2 studies. Additionally, DB-OTO aims to evaluate dose escalation and its impact on mitigating hearing loss through combined Phase 1 and Phase 2 investigations. Cohort 2 is another study that investigates potential treatments for hearing loss across different phases of research. Furthermore, a noteworthy trial examines the efficacy of standard cisplatin-based chemotherapy when combined with sodium thiosulfate and mannitol for addressing hearing loss concerns. Finally, a Phase 4 trial explores statin usage as an intervention strategy against hearing loss. These diverse clinical trials demonstrate the commitment of scientists towards finding effective solutions for improving auditory health in those affected by hearing impairment.
What hearing loss clinical trials were recently completed?
Several clinical trials focusing on hearing loss have recently been completed, offering insights into potential treatments and advancements in this field. These trials include the study of a new medication sponsored by Stanford University School of Medicine, which concluded in November 2021. Another trial exploring innovative gene therapy for hearing loss was successfully conducted by the University of Miami Miller School of Medicine, concluding in September 2021. The completion of these trials brings us closer to better understanding and addressing hearing loss, providing hope for those affected by this condition.